Midlife Women's Health 2025: A Multidisciplinary Approach to Care

Description

Midlife Women’s Health 2025 provides a multi-disciplinary approach to the care of menopausal women. Advances in research, technology, and pharmacology increase options available for midlife women, but this rapidly changing knowledge-base presents a challenge for clinicians. Care for women at this stage of life is optimized by education on a range of medical concerns provided by experts from a wide variety of medical specialties. Given demographic changes in the US population, midlife women are becoming an increasingly important group served by health care professionals, with needs that cross many areas of medical expertise.

In this educational activity, a multidisciplinary group of experts from Massachusetts General Hospital will present on the evaluation and management of osteoporosis, gastrointestinal malignancy, stress, obesity, substance use disorder, anxiety, sexual dysfunction, breast cancer, and menopausal hormone therapy to assist clinicians in caring for their midlife patients.

Target Audience

This activity is intended for physicians and advance practice nurses in primary care, gynecology, general surgery, internal medicine, endocrinology, psychiatry, gynecological oncology, cardiology, and preventive medicine who provide care to midlife women. Physicians and advance practice nurses in-training also are encouraged to attend.

Learning Objectives

Upon completion of this activity, participants will be able to:

1. Assess midlife women for osteoporosis and utilize effective therapies.
2. Identify risk factors for gastrointestinal malignancies to optimize screening strategies and outcomes.
3. Integrate mind body strategies to reduce the adverse impact of stress on midlife women's health.
4. Recognize the link between exercise, obesity and cardiovascular disease in women to improve health.
5. Assess midlife women for alcohol and opioid use disorder and guide the use of available treatment options.
6. Employ a greater understanding of anxiety in women to reduce disease burden.
7. Integrate behavioral and pharmacologic strategies to improve sexual function in women.
8. Formulate a strategy to identify women at increased risk of breast cancer to optimize care.
9. Evaluate symptomatic midlife women for menopausal hormone therapy, incorporating an individualized assessment of risks and benefits.

Friday, May 9, 2025

7:45 a.m. - Welcome & Introductory Remarks

Jan Shifren, MD

8:00 a.m. - Osteoporosis: Treatment Options to Reduce Fracture Risk

Joy Tsai, MD

8:45 a.m. - Gastrointestinal Malignancy at Midlife: Risk Assessment and Screening Strategies

Daniel Chung, MD

9:20 a.m. - Q & A

9:30 a.m. - Stress Reduction at Midlife: A Mind Body Approach

John W Denninger, MD, PhD

10:05 a.m. - Q & A

10:15 a.m. - Break

10:30 a.m. - Battling the Bulge: Exercise, Weight and Cardiovascular Health at Midlife

James Sawalla Guseh, II, MD

11:05 a.m. - Q & A

11:15 a.m. - Alcohol and Opioid Use Disorder at Midlife: Optimizing Care

Sarah Wakeman, MD

11:50 a.m. - Q & A

12:00 p.m. - Lunch Break

1:00 p.m. - Anxiety in Midlife Women: Therapeutic Options

Noreen Reilly Harrington, PhD

1:35 p.m. - Q & A

1:45 p.m. - Sexual Dysfunction in Women: Causes and Care

Jan Shifren, MD

2:20 p.m. - Q & A

2:30 p.m. - Breast Cancer: Update on Screening Algorithms and Treatment Options

Francys Verdial, MD

3:05 p.m. - Q & A

3:15 p.m. - Break

3:30 p.m. - Menopausal Hormone Therapy: Update for 2025

Tara Iyer, MD

4:05 p.m. - Q & A

4:15 p.m. - Everything You Wanted to Know About Menopause, But Were Afraid to Ask

Panel of Experts:

Isaac Schiff, MD

Kathryn Rexrode, MD, MPH

Linda Kelly, DNP, ANP-BC

5:00 p.m. - Program Concludes